TCM
RBOT

Tuttle Capital Management’s Vicarious Surgical RBOT Stock Holding History

Tuttle Capital Management’s Portfolio RBOT Stock Details RBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-5,492
Closed -$1.64M – 351
2021
Q1 		$1.64M Buy
5,492
+4,346
+379% +$1.33M 0.65% 45
2020
Q4 		$349K Buy
+1,146
New +$337K 0.27% 115

Other funds holding RBOT

PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
AC
Athanor Capital New York $24.6M AUM 2.49% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Capstone Investment Advisors
Capstone Investment Advisors New York $57.4B AUM 26.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return

Tuttle Capital Management's RBOT Position: Q2 2021 in Review

Tuttle Capital Management sold out of Vicarious Surgical (RBOT) in Q2 2021, closing a stake of 5,492 shares — an estimated $1.64M sold.

Tuttle Capital Management first reported a position in RBOT in Q4 2020 and held it in 2 quarters. The position peaked at $1.64M in Q1 2021. 98 funds tracked by Wall St. Rank hold RBOT as of Q2 2021.

  • Tuttle Capital Management reported no remaining Vicarious Surgical position as of Q2 2021 after selling out during the quarter.
  • Tuttle Capital Management sold 5,492 Vicarious Surgical shares in Q2 2021, an estimated $1.64M.
  • Tuttle Capital Management first reported a position in Vicarious Surgical in Q4 2020 and held it in 2 quarters.
  • Tuttle Capital Management's Vicarious Surgical position peaked at $1.64M in Q1 2021.
  • 98 funds tracked by Wall St. Rank held Vicarious Surgical as of Q2 2021.

Based on Tuttle Capital Management's 13F filing for Q2 2021, filed 21 Jul 2021.